NCT07248631 Combined Effects of Foot-Ankle Therapeutic Exercises and Mindful Walking in Patients With Diabetic Polyneuropathy
| NCT ID | NCT07248631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Diabetic Polyneuropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2024-10-17 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2024-10-17 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the combined effects of foot ankle therapeutic exercises and mindful walking on pain, foot and ankle disability, and quality of life in patients with diabetic polyneuropathy. This study seeks to evaluate the efficacy of these interventions in improving clinical outcomes and enhancing the overall well-being of individuals with diabetic polyneuropathy.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with diabetic polyneuropathy (DPN) confirmed by medical history and clinical examination. * Experience pain and disability in foot/ankle, with a Numeric Pain Rating Scale (NPRS) score ≥ 4. * Independent walking ability for at least 10 m. * Age (40-75) years. * Ability to understand and follow exercise instructions. * A maximum of one amputated toe, not being the hallux. * Willingness to participate in the study and provide informed consent. Exclusion Criteria: * Presence of an active plantar ulcer or gangrene. * History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period. * Arthroplasty and/or orthosis of lower limbs or indication of lower limb arthroplasty throughout the intervention period. * Participating in other exercise programs or studies. * Dementia or inability to give consistent information. * Diagnosis of neurological diseases. * Neuropathic pain due to other causes (e.g., HIV, chemotherapy). * Major vascular complications and/or severe retinopathy.
Contact & Investigator
Fatima Tariq, MS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07248631 clinical trial?
This trial is open to participants of all sexes, aged 40 Months or older, up to 75 Months, studying Diabetic Polyneuropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07248631 currently recruiting?
Yes, NCT07248631 is actively recruiting participants. Contact the research team at fatima.tariq@rihah.edu.pk for enrollment information.
Where is the NCT07248631 trial being conducted?
This trial is being conducted at Multan, Pakistan.
Who is sponsoring the NCT07248631 clinical trial?
NCT07248631 is sponsored by Riphah International University. The principal investigator is Fatima Tariq, MS at Riphah International University. The trial plans to enroll 38 participants.